Feasibility of a Multi-omics Platform for Hematological Malignancies

Recruiting now · Not applicable

Conditions studied: Myeloma Multiple, Chronic Leukemia, Acute Leukemia, Myeloproliferative Disorders, Lymphoproliferative Disorders, Myelodysplastic Disorders

In brief

This is a biological study based on a collaborative effort involving several Italian haematology centres (including the coordinating centre). The study will be conducted retrospectively and prospectively using bone marrow (BM) or peripheral blood (PB) samples, lymph node or tissue biopsies with metastatic involvement, and other biological fluids, such as cerebrospinal fluid and pathological pleural effusion.

Key facts

Study ID
NCT07445438
Run by
Azienda Ospedaliero-Universitaria di Parma
People needed
1040
Starts
2025-03-31
Expected to finish
2030-03-01
Last updated by the study team
2026-03-03

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.